Welcome!

News Feed Item

Renal Pain Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Renal Pain Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.html

Renal Pain Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Renal Pain Global Clinical Trials Review, H2, 2014" provides data on the Renal Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Pain 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Pain to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Renal Pain 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Renal Pain Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
Emcure Pharmaceuticals Ltd. 31
Clinical Trial Overview of Emcure Pharmaceuticals Ltd. 31
Clinical Trial Overview of Top Institutes / Government 32
Tehran University of Medical Sciences 32
Clinical Trial Overview of Tehran University of Medical Sciences 32
Seoul National University Hospital 33
Clinical Trial Overview of Seoul National University Hospital 33
University of Minnesota 34
Clinical Trial Overview of University of Minnesota 34
The International Kidney Stone Institute 35
Clinical Trial Overview of The International Kidney Stone Institute 35
Yale University 36
Clinical Trial Overview of Yale University 36
Ahvaz Jundishapur University of Medical Sciences 37
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 37
Isfahan University of Medical Sciences 38
Clinical Trial Overview of Isfahan University of Medical Sciences 38
Department of Health, UK 39
Clinical Trial Overview of Department of Health, UK 39
University of Monastir 40
Clinical Trial Overview of University of Monastir 40
Korea Institute of Oriental Medicine 41
Clinical Trial Overview of Korea Institute of Oriental Medicine 41
Five Key Clinical Profiles 42
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 64

List of Tables

Renal Pain Therapeutics, Global, Clinical Trials by Region, 2014* 7
Renal Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Renal Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Renal Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Renal Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Renal Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Renal Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Renal Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Pain Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Renal Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Renal Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Renal Pain Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Renal Pain Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Renal Pain Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Renal Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Renal Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Renal Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Renal Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Renal Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 30
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Emcure Pharmaceuticals Ltd., 2014* 31
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 32
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 33
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 34
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The International Kidney Stone Institute, 2014* 35
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 36
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014* 37
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014* 38
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014* 39
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Monastir, 2014* 40
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea Institute of Oriental Medicine, 2014* 41

List of Figures

Renal Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Renal Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Renal Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Renal Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Renal Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Renal Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Renal Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Renal Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Renal Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Renal Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Renal Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Renal Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Renal Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Renal Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Renal Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 63


Read the full report:
Renal Pain Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
Your homes and cars can be automated and self-serviced. Why can't your storage? From simply asking questions to analyze and troubleshoot your infrastructure, to provisioning storage with snapshots, recovery and replication, your wildest sci-fi dream has come true. In his session at @DevOpsSummit at 20th Cloud Expo, Dan Florea, Director of Product Management at Tintri, provided a ChatOps demo where you can talk to your storage and manage it from anywhere, through Slack and similar services with...
Evan Kirstel is an internationally recognized thought leader and social media influencer in IoT (#1 in 2017), Cloud, Data Security (2016), Health Tech (#9 in 2017), Digital Health (#6 in 2016), B2B Marketing (#5 in 2015), AI, Smart Home, Digital (2017), IIoT (#1 in 2017) and Telecom/Wireless/5G. His connections are a "Who's Who" in these technologies, He is in the top 10 most mentioned/re-tweeted by CMOs and CIOs (2016) and have been recently named 5th most influential B2B marketeer in the US. H...
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
"With Digital Experience Monitoring what used to be a simple visit to a web page has exploded into app on phones, data from social media feeds, competitive benchmarking - these are all components that are only available because of some type of digital asset," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"Venafi has a platform that allows you to manage, centralize and automate the complete life cycle of keys and certificates within the organization," explained Gina Osmond, Sr. Field Marketing Manager at Venafi, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Michael Maximilien, better known as max or Dr. Max, is a computer scientist with IBM. At IBM Research Triangle Park, he was a principal engineer for the worldwide industry point-of-sale standard: JavaPOS. At IBM Research, some highlights include pioneering research on semantic Web services, mashups, and cloud computing, and platform-as-a-service. He joined the IBM Cloud Labs in 2014 and works closely with Pivotal Inc., to help make the Cloud Found the best PaaS.
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discussed how a new approach is neces...
"This week we're really focusing on scalability, asset preservation and how do you back up to the cloud and in the cloud with object storage, which is really a new way of attacking dealing with your file, your blocked data, where you put it and how you access it," stated Jeff Greenwald, Senior Director of Market Development at HGST, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
"We work around really protecting the confidentiality of information, and by doing so we've developed implementations of encryption through a patented process that is known as superencipherment," explained Richard Blech, CEO of Secure Channels Inc., in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
The Founder of NostaLab and a member of the Google Health Advisory Board, John is a unique combination of strategic thinker, marketer and entrepreneur. His career was built on the "science of advertising" combining strategy, creativity and marketing for industry-leading results. Combined with his ability to communicate complicated scientific concepts in a way that consumers and scientists alike can appreciate, John is a sought-after speaker for conferences on the forefront of healthcare science,...